Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis

Conditions: Atopic Dermatitis Interventions: Biological: GR1802 injection; Biological: placebo Sponsors: Genrix (Shanghai) Biopharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials